The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes
- Science · Life Sciences
Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Smart, fast, and built for pharma and biotech professionals who need to stay ahead. Transcripts, deal intelligence, and the daily newsletter at https://thepharmacloseout.com/. Host voices are AI-created.
Also on
Recent episodes
- Daily Roundup | Acumen Ends Alzheimer's Antibody After Phase 2 Miss & Inovio's Voceryq Wins Accelerated Approval
- Daily Roundup | Iovance Lung Data Points to a Subgroup & Ono Plans New Pain Studies After 3 Misses
- Daily Roundup | Genmab's Cancer Survival Gain & Lilly's Retatrutide Dose Trade-Off
- Daily Roundup | Artiva Ends AlloNK, Cuts 94% of Staff & Ferring Agrees to Buy Gameto
- Daily Roundup | BioNTech/DualityBio Breast ADC Gain Called Modest & Merck's sac-TMT Survival Edge Under FDA Review
- Week in Review | Amgen's Survival Gain, Roche's KRAS Challenge & Gilead's IBD Deal
- Daily Roundup | Remibrutinib Cuts MS Relapses & Iza-bren Improves Breast Cancer PFS
- UEG Week 2026 Debrief: Takeda's Treat-to-Target Test & Duvakitug's 44-Week TL1A Read
- Daily Roundup | Merck-Moderna mRNA Cuts Melanoma Recurrence or Death & AbbVie HS Drug Hits Phase 3 Goal
- Daily Roundup | Brepocitinib Holds Uveitis Control Off Steroids; Oral Olorofim Shows Far Fewer Kidney Events